A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products

BACKGROUND: Artemisinin-based fixed dose combination (FDC) products are recommended by World Health Organization (WHO) as a first-line treatment. However, the current artemisinin FDC products, such as β-artemether and lumefantrine, are inherently unstable and require controlled distribution and stor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suleman, Sultan, Vandercruyssen, Kirsten, Wynendaele, Evelien, D’Hondt, Matthias, Bracke, Nathalie, Duchateau, Luc, Burvenich, Christian, Peremans, Kathelijne, De Spiegeleer, Bart
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651282/
https://ncbi.nlm.nih.gov/pubmed/23631682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados